Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Life Sciences and Osaka University Team Up

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Top four graduate students to be hosted at GE Healthcare Life Science’s Uppsala site.

GE Healthcare Life Sciences has announced a joint program with Osaka University to offer students access to GE Healthcare’s cutting-edge expertise in training and technologies for biopharmaceutical research and manufacturing, to help support future growth of the sector in Japan.

The program, Interdisciplinary Program for Biomedical Sciences (IPBS), is Osaka University’s government-funded commitment to graduate education, which aligns with GE Healthcare Japan’s “Life Sciences Academy,” a GE Healthcare initiative launched in April 2013 with the objective of supporting the development of life sciences researchers in Japan.

Of the 14 IPBS graduate students, four will visit GE Healthcare Life Science’s Uppsala site for three weeks from 19 August to 6 September 2013.

While at GE Healthcare in Uppsala, the Osaka University students will experience day-to-day life in an R&D laboratory, closely working with GE Healthcare scientists and engineers.

The students will receive comprehensive training in GE Healthcare’s advanced bioprocessing technologies and gain first-hand experience of protein interaction analysis and laboratory-scale protein purification using GE Healthcare instruments including Biacore™ and MicroCal™ systems for label-free analyses and ÄKTA™ pure chromatography systems.

Anders Fält, Head of R&D, Bio-Analysis Systems, GE Healthcare Life Sciences, commented, “This joint program with Osaka University is a great way to share our knowledge and expertise, as well as encourage and inspire the life sciences researchers and manufacturing professionals of tomorrow. Specifically, we’re providing an opportunity for students from one of the leading Japanese universities to be introduced to the latest technologies and workflows from GE Healthcare, taking them closer to becoming tomorrow’s leading life scientists.”

Kiyoshi Takeda, MD, PhD, the coordinator of the Interdisciplinary Program for Biomedical Sciences (IPBS) at Osaka University, commented, “Our program seeks to educate young life scientists so that they will play an active role at the front lines of global-scale research collaborations whether it would be in the industry, academic or government sectors, during their careers. We strongly believe our students will gain valuable experience from the internship at the GE Healthcare Life Sciences R&D Center in Uppsala. Our joint program with GE Healthcare is an excellent example of cooperation between university and industry, a collaboration that has not been possible in the traditional Japanese education system. We hope such a collaborative educational program will strengthen the relations between academia and industry for the coming generations, leading the way to advanced treatment research for intractable diseases.”

During their visit, on which they will be joined by their Professor, Masayuki Miyasaka, a world-renowned immunologist, the students will also meet scientists at the SciLifeLab at the Karolinska Institutet, one of the largest medical universities in Europe.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences to Open Biopharmaceutical Technology and Training Laboratory in Turkey
Supports Turkey’s ambitions to expand domestic biopharmaceutical industry. Laboratory will be a key component of GE’s new Innovation Center in Istanbul.
Friday, November 14, 2014
GE Healthcare Life Sciences Named as Finalist for Four Bioprocess Industry Awards
Awards celebrate and recognize the outstanding people, organizations and technologies.
Saturday, October 04, 2014
GE Healthcare Life Sciences to Create New US Headquarters
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.
Wednesday, August 20, 2014
GE Healthcare Appoints Emmanuel Ligner as General Manager
Emmanuel will oversee all worldwide commercial activities of Company's rapidly growing BioProcess business.
Friday, April 11, 2014
GE Healthcare to Build KUBio Factory for JHL Biotech in China
New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia.
Thursday, September 26, 2013
GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.
Acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of recombinant proteins, antibodies and vaccines.
Tuesday, May 15, 2012
Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!